Paris prize spotlights MS research
(From left) Dr. Christophe Charpentier, Prof. Michel Goldberg Prof. Catherine Lubetzki, Olivier Laureau, Prof. Gérard Friedlander, and David Weizmann, Director General of Weizmann France
As life expectancy increases, scientists are confronted with more and more age-related health issues—neurodegenerative diseases being of particular importance. The 7th Pasteur- Weizmann/Servier Prize was therefore dedicated to research on neurodegenerative pathologies and honored Prof. Catherine Lubetzki for her groundbreaking work on myelin regeneration in the treatment of multiple sclerosis. Prof. Lubetzki is Head of the University Medical Neuroscience Department of Sorbonne University and Medical Director of the Paris Brain Institute.
The Pasteur-Weizmann/Servier Prize, awarded every three years, was established in 2003 by the Pasteur-Weizmann Council and L’Institut Servier. Maurice Lévy, President of Weizmann France, Prize, which rewards the work of an entire team of clinician- researchers,” said Prof. Lubetzki. “We are very proud of this award, and it encourages us to continue our research.”
“This prize is dedicated to promoting fundamental research with high therapeutic potential for the benefit of patients,” said Dr. Christophe Charpentier, Delegate-General of the Servier Institute. “This is perfectly illustrated by Catherine Lubetzki’s research work, which has led to the development of new therapeutic strategies for the prevention of Chairman of the Scientific Committee of the Servier Institute; Prof. Michel Goldberg, Professor Emeritus at the Pasteur Institute, President of the Scientific Council of Weizmann France, and an honorary member of the Pasteur- Weizmann Council; Prof. Jean- François Joanny, Collè ge de France; Francis Kalifat, President of the CRIF (the umbrella organization for Jewish groups in France); Ariel Goldmann, President of the Fondation du Judaïsme Français; and Alain Grosmann, treasurer of Weizmann France.
